Skip to main content

Advertisement

Table 2 Characteristics of the study population, according to the occurrence or not of restenosis (n = 54)

From: Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study

Parameter Univariate analysis Multivariate analysis
Re-PCI p OR [95% CI] p
Yes (n = 4) No (n = 50)
Age (years), median [IQR] 59.5 [58.2–60.7] 60 [57.7–63] 0.714   
Sex, no. (%)    0.386   
 M 4 (100) 42 (84)    
 F 0 (−) 8 (16)    
BMI, kg/m2, median [IQR] 25.3 [24.8–26.7] 27.2 [25.8–28.1] 0.159   
Blood pressure (mmHg), median [IQR]
 Systolic 130 [115–137.5] 130 [120–131.2] 1.000   
 Diastolic 80 [72.5–80] 80 [70–80] 0.714   
Hypertension, no. (%) 1 (25) 14 (28) 0.897   
Smoke, no. (%) 4 (100) 39 (78) 0.293   
Cholesterol (mg/dL), median [IQR]
 Total 157 [147.5–180.7] 174.5 [147.5–192] 0.555   
 HDL 34.5 [31.7–41] 43 [35–51.2] 0.066   
 LDL 90.5 [86–116] 109 [70.2–122.5] 0.874   
Triglycerides (mg/dL), median [IQR] 141.5 [121.5–166.7] 125.5 [103–151.5] 0.327   
Glycemia (mg/dL), median [IQR]
 Baseline 93.5 [86.2–102.2] 87 [79.7–90] 0.066   
 2 h 132.5 [117.7–136.7] 106 [93–123] 0.021   
Glycated hemoglobin (%), median [IQR] 5.6 [5.3–5.8] 5.2 [5–5.5] 0.051   
Insulin (µU/mL), median [IQR] 9.8 [9.4–10] 3.6 [2.8–4.7] 0.003   
HOMA IR, median [IQR] 2.23 [2.1–2.4] 0.75 [0.57–0.97] 0.003   
Creatinine (mg/dL), median [IQR] 1 [1–1.16] 1 [0.8–1.1] 0.266   
Hemoglobin (mg/dL), median [IQR] 14.2 [13.2–14.5] 14.3 [13.3–15.2] 0.534   
Adiponectin (µg/mL), median [IQR] 7 [6–8] 11.5 [10–14] 0.000 0.206 [0.053–0.796] 0.022
Resistin (ng/mL), median [IQR] 13 [5.2–15.5] 6.5 [4–8.2] 0.137   
TNF-alpha (ng/mL), median [IQR] 18.5 [11–20.7] 8 [7–10] 0.008   
Time RE-PCI, median [IQR] 8.5 [4–21.2] 29.5 [13.5–34] 0.019   
Follow-up duration (months), median [IQR] 30 [25.7–32.7] 29.5 [13.5–34] 1.000   
Death, no. (%)
 Cardiovascular/other causes 0 (−)/− 0 (−)/1 (2) 0.775